ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-07-03	€2.660	+0.76%	5,087
26-07-02	€2.640	-5.04%	67,260
26-07-01	€2.780	0.00%	7,954
26-06-30	€2.780	+11.20%	8,384
26-06-29	€2.500	+2.46%	4,358

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-03 EDT			5-day change	1st Jan Change
2.660 ^EUR	+5.14%		+9.02%	-11.33%

07-02	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026	CI
06-12	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI

Market Cap	42.74M 48.9M 39.28M 36.62M 69.45M 4.66B 70.5M 472M 183M 2.29B 184M 180M 7.89B	P/E 2024	123x	P/E 2025	50x
Enterprise Value	43.68M 49.96M 40.14M 37.41M 70.96M 4.76B 72.04M 482M 187M 2.34B 188M 184M 8.06B	EV / Sales 2024	7,098,474x	EV / Sales 2025	6,185,843x
Free-Float	2.52%	Yield 2024	2.03%	Yield 2025	3.67%

07-02	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026	CI
06-12	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI
06-12	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services	MT
06-12	ABL Diagnostics Secures Multi-Year Contract with CDL Pharma
06-10	ABL Diagnostics Offers to Buy Texcell	MT
06-05	ABL divests block of ABL Diagnostics shares
06-01	ABL Diagnostics Société anonyme Provides Earnings Guidance for the Fiscal Year Ending December 31, 2026	CI
05-18	ABL Diagnostics Société anonyme Proposes Dividend for the Financial Year Ended December 31, 2025, Payable on July 7, 2026	CI
05-06	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-14	Abl Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its Vela Product Line in A Targeted Segment of the French Market	CI
25-10-01	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-05	ABL Diagnostics Société anonyme announced that it expects to receive funding from Alumni Capital Management	CI
25-05-08	ABL Diagnostics Société anonyme announces Annual dividend, payable on July 01, 2025	CI

07-02	ABL Diagnostics – Approval of Dividend Distribution for Fiscal Year 2025	BU
06-18	ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified	BU
06-12	ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031	BU
06-10	ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France	BU
06-09	ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 – Terms for Making Available or Consulting Preparatory Documents	BU

ABL Diagnostics Stock

Stocks

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Valuation: ABL Diagnostics

Chart: ABL Diagnostics

Latest news : ABL Diagnostics

Press Releases: ABL Diagnostics

News in other languages: ABL Diagnostics

Quotes and Performance

Course Extremes

Managers and Directors: ABL Diagnostics

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

07-02	ABL Diagnostics : Approbation du versement de dividendes au titre de l’exercice 2025
07-02	ABL Diagnostics - Approbation du versement de dividendes au titre de l’exercice 2025
06-26	Agenda des dividendes et des AG France : embouteillage de fin de semestre
06-18	ABL Diagnostics : trajectoire de croissance confirmée et fort levier de revalorisation identifié
06-12	ABL Diagnostics remporte un contrat pluriannuel avec CDL Pharma

1 day	+5.14%
1 week	+9.02%
Current month	-4.32%
1 month	-14.19%
3 months	-6.34%
6 months	-30.73%
Current year	-11.33%

1 week	2.44	2.96
1 month	2.2	2.96
Current year	2.12	5
1 year	2.12	5.75
3 years	2.12	9.7
5 years	1.99	26
10 years	1.28	26

Director	Title	Age	Since
Noemie Sadoun CHM	Chairman	-	-
Laure Raffaelli BRD	Director/Board Member	-	-
Deborah Szafir BRD	Director/Board Member	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
06-01	Advanced Biological Laboratories SA	Sell	Company	-57,692	0.3580%
05-26	Advanced Biological Laboratories SA	Sell	Company	-51,900	0.3221%
03-16	Advanced Biological Laboratories SA	Sell	Company	54,745	0.3397%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABL DIAGNOSTICS	+5.14%	+9.02%	-50.74%	-70.28%	48.9M
ABBOTT LABORATORIES	+3.49%	+1.36%	-29.04%	-11.02%	166B
MEDTRONIC PLC	+5.04%	+2.73%	-5.88%	-4.53%	106B
CENCORA, INC.	+2.80%	+3.63%	+0.09%	+55.31%	57.69B
HOYA CORPORATION	+1.33%	+1.39%	+53.16%	+49.84%	53.78B
BECTON, DICKINSON AND COMPANY	+3.39%	+1.39%	-10.26%	-39.65%	43.56B
MEDLINE INC.	+3.50%	+11.11%	-	-	36.52B
DEXCOM, INC.	+3.47%	+1.58%	-14.08%	-43.91%	27.49B
WEST PHARMACEUTICAL SERVICES, INC.	+0.20%	+4.24%	+64.56%	-3.33%	25.84B
STERIS PLC	+2.78%	+1.17%	-8.15%	-0.43%	21.27B
Average	+3.11%	+5.11%	-0.04%	-7.56%	53.89B
Weighted average by Cap.	+3.31%	+3.80%	-3.84%	+1.04%

	2024	2025
Net sales	5.87 6.71 5.39 5.03 9.54 639.27 9.68 64.76 25.17 314.24 25.2 24.66 1.08K	7.97 9.11 7.32 6.82 12.94 867.59 13.14 87.88 34.16 426.46 34.2 33.47 1.47K
Net income	285K 326K 262K 244K 463K 31.06M 470K 3.15M 1.22M 15.27M 1.22M 1.2M 52.61M	987K 1.13M 907K 845K 1.6M 107M 1.63M 10.89M 4.23M 52.83M 4.24M 4.15M 182M
Net Debt	2.02M 2.32M 1.86M 1.73M 3.29M 220M 3.34M 22.33M 8.68M 108M 8.69M 8.5M 373M	933K 1.07M 857K 799K 1.52M 102M 1.54M 10.29M 4M 49.93M 4M 3.92M 172M